Latest News
The stock's been going up.
Via The Motley Fool · June 17, 2026
Lockheed Martin received $2.8 billion in new Department of Defense contracts and holds a $194 billion backlog, suggesting its recent share price decline reflects geopolitical overreaction rather than demand erosion.
Via MarketBeat · June 17, 2026
Bread Financial stock delivered strong earnings and improving credit performance, but investors must weigh future growth prospects against a higher valuation.
Via MarketBeat · June 17, 2026
Dutch Bros and Sweetgreen both built cult followings, but only one is a clear buy right now. Here's the winner of this head-to-head stock showdown.
Via The Motley Fool · June 17, 2026
Trane Technologies (NYSE:TT) Proves Its Quality Investing Mettle as a Top Caviar Cruise Screener Pickchartmill.com
Via Chartmill · June 17, 2026
It's not the best situation, but it's also far from hopeless.
Via The Motley Fool · June 17, 2026
It's hard to go wrong here, but some crucial nuances decide this comparison.
Via The Motley Fool · June 17, 2026
Asset size, track record, and portfolio makeup set these two low-cost sector funds apart for investors seeking financial sector exposure.
Via The Motley Fool · June 17, 2026
Nova Ltd. (NASDAQ:NVMI) Passes the Caviar Cruise Quality Screen with Strong Growth and Profitabilitychartmill.com
Via Chartmill · June 17, 2026
Semiconductor Momentum Surges on AI Capex, but Valuations Signal a Selective Rallychartmill.com
Via Chartmill · June 17, 2026
Ollie's continues to post earnings beats and sales growth, but the stock has lagged other discount retailers despite a bullish analyst outlook.
Via MarketBeat · June 17, 2026
This growth stock is finding tremendous success in the competitive retail coffee market.
Via The Motley Fool · June 17, 2026
SpaceX shares took off like a rocket.
Via The Motley Fool · June 17, 2026
Iron Mountain serves more than 240,000 customers, including some of the hyperscalers that are ramping up their AI spending.
Via The Motley Fool · June 17, 2026
The brand's sales and margins are tanking amid weak consumer spending.
Via The Motley Fool · June 17, 2026
Uniqure stock catapulted Wednesday after announcing the FDA would allow it to re-file its Huntington's disease gene therapy.
Via Investor's Business Daily · June 17, 2026
These two low-cost defensive ETFs share many similarities, but one is clearly a more attractive buy.
Via The Motley Fool · June 17, 2026
Something real is happening in the NCR property marketIt doesn't show up in newspaper headlines. It happens 1 family at a time, across site visits and shor
Via Talk Markets · June 17, 2026
The acquisition of Roku transforms Fox into a powerhouse capable of completely dominating the lucrative connected television advertisement industry.
Via MarketBeat · June 17, 2026
Goldman Sachs raised its estimate for Tesla's Q2 deliveries by 3.7%. Shares of the Elon Musk-led automaker fell about 1% Wednesday.
Via Investor's Business Daily · June 17, 2026
Amazon and Alphabet are both leaders in the AI race, but one of them looks more compelling.
Via The Motley Fool · June 17, 2026
Wall Street expects the new Fed chief to withhold his dot from the dot plot.
Via Investor's Business Daily · June 17, 2026
Plastic and reconstructive surgery practices operate in one of the most documentation-intensive and reimbursement-sensitive areas of healthcare. Providers
Via Talk Markets · June 17, 2026